← Leaderboards
Emmanuel Oluwadare Balogun
Ahmadu Bello University
$576,720
Attributed
$576,720
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $115.3K · FY2021–25$200K$150K$100K$50K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$576,720 · 1
By mechanism
K43$576,720 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Drug Interactions”
- John Damon Chodera · Sloan-Kettering Inst Can Research$32,399,541
- Nader Fotouhi · Global Alliance For Tb Drug Development$28,468,137
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$20,810,724
- Emmanuel Aja Oga · Research Triangle Institute$16,110,065
- Badri N Vardarajan · University Of Miami School Of Medicine$15,378,463
- James Dale Berry · Brigham And Women'S Hospital$15,344,018
Research focus
Drug InteractionsAfricaDrug DevelopmentDrug DiscoveryAfrica South Of The SaharaAlternative OxidaseAnimalsDrug DesignBloodAfrican TrypanosomiasisCaliforniaCamelsCategoriesCattleCellsCessation Of LifeAfricanAdoptedCommunicable DiseasesDesignDisability-Adjusted Life YearsDoctor Of PhilosophyDrug CandidateEconomic Development
Grant awards (5)
Multi-target approach to rational design of novel therapeutics for human African trypanosomiasis$115,344
K43 · FY2025 · TW · contact PI
Multi-target approach to rational design of novel therapeutics for human African trypanosomiasis$115,344
K43 · FY2024 · TW · contact PI
Multi-target approach to rational design of novel therapeutics for human African trypanosomiasis$115,344
K43 · FY2023 · TW · contact PI
Multi-target approach to rational design of novel therapeutics for human African trypanosomiasis$115,344
K43 · FY2022 · TW · contact PI
Multi-target approach to rational design of novel therapeutics for human African trypanosomiasis$115,344
K43 · FY2021 · TW · contact PI